Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: A pilot study

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 2, 2011, Pages 198-208

  Aghdassi, Elaheh ^a   Ma, David W L ^b   Morrison, Stacey ^a   Hillyer, Lynn M ^b   Clarke, Shannon ^b   Gladman, Dafna D ^a,c   Urowitz, Murray B ^a,c   Fortin, Paul R ^a,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

3 fatty acids; fatty acids; inflammation; systemic lupus erythematosus

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PREDNISONE; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; METABOLITE; PILOT STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PILOT PROJECTS; PLASMA; PREDNISONE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 79954592883     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110386378     Document Type: Article

References (74)

1. Molokhia M., Hoggart C., Patrick AL, et al. Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population. Hum Genet. 2003 ; 112: 310-318. (Pubitemid 36869089)
2. Johnson AE, Gordon C., Palmer RG, Bacon PA The prevalence and incidence of systemic lupus erythematosus in Birmingham, England-Relationship to ethnicity and country of birth. Arthritis Rheum. 1995 ; 38: 551-558.
3. Jiménez S., Cervera R., Font J., Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003 ; 25: 3-11. (Pubitemid 36819439)
4. Samanta A., Roy S., Feehally J., Symmons DP The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol. 1992 ; 31: 679-682.
5. Hochberg M. The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. 5th ed. Baltimore, MD: Williams & Wilkins ; 1997: 49-65.
6. Hochberg MC The epidemiology of lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. 2nd ed. Philadelphia, PA: Lea & Febiger ; 1993: 49-57.
7. Uramoto KM, Michet CJ, Thumboo J., Sunku J., O'Fallon WM, Gabriel SE Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 ; 42: 46-50. (Pubitemid 29042569)
8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277. (Pubitemid 13221242)
9. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725.
10. Kotzin BL Systemic lupus erythematosus. Cell. 1996 ; 85: 303-306. (Pubitemid 26160701)
11. Hahn BH Antibodies to DNA. N Engl J Med. 1998 ; 338: 1359-1368. (Pubitemid 28216666)
12. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976 ; 60: 221-225.
13. Manzi S., Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am J Epidemiol. 1997 ; 145: 408-415. (Pubitemid 27084212)
14. Ward MM Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 338-346. (Pubitemid 29072852)
15. Esdaile JM, Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2331-2337. (Pubitemid 32977500)
16. Bruce IN, Gladman DD, Urowitz MB Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am. 2000 ; 26: 257-278. (Pubitemid 30198759)
17. Petri M., Spence D., Bone LR, Hochberg MC Coronary artery disease risk factors in the Johns Hopkins Lupus cohort: Prevalence, recognition by patients, and preventive practices. Medicine. 1992 ; 71: 291-302.
18. Bruce IN Atherogenesis and autoimmune disease: the model of lupus. Lupus. 2005 ; 14: 687-690. (Pubitemid 41413292)
19. Bruce IN, Urowitz MB, Gladman DD, Ibanez D., Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum. 2003 ; 48: 3159-3167. (Pubitemid 37409327)
20. Chung CP, Oeser A., Avalos I., Raggi P., Stein CM Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus. 2006 ; 15: 562-569. (Pubitemid 44661742)
21. Petri M., Perez-Gutthann S., Spence D., Hochberg MC Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992 ; 93: 513-519.
22. Willerson JT, Ridker PM Inflammation as a cardiovascular risk factor. Circulation. 2004 ; 109: 2-10.
23. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306.
24. van Oostrom AJ, Sijmonsma TP, Verseyden C., et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003 ; 44: 576-583. (Pubitemid 37279707)
25. Napolitano M., Bravo E. Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur J Clin Invest. 2005 ; 35: 482-490. (Pubitemid 41153202)
26. Luu NT, Madden J., Calder PC, et al. Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J Nutr. 2007 ; 137: 2769-2774. (Pubitemid 350255311)
27. Alipour A., van Oostrom AJ, Izraeljan A., et al. Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol. 2008 ; 28: 792-797. (Pubitemid 351651339)
28. Aeberli I., Beljean N., Lehmann R., l'Allemand D., Spinas GA, Zimmermann MB The increase of fatty acid-binding protein aP2 in overweight and obese children: interactions with dietary fat and impact on measures of subclinical inflammation. Int J Obes (Lond). 2008 ; 32: 1513-1520.
29. Keys A., Menotti A., Karvonen MJ, et al. The diet and 15-year death rate in the 7 countries study. Am J Epidemiol. 1986 ; 124: 903-915. (Pubitemid 17207259)
30. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997 ; 337: 1491-1499. (Pubitemid 27495774)
31. McGee DL, Reed DM, Yano K., Kagan A., Tillotson J. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to nutrient intake. Am J Epidemiol. 1984 ; 119: 667-676. (Pubitemid 14142805)
32. Oh K., Hu FB, Manson JE, Stampfer MJ, Willett WC Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol. 2005 ; 161: 672-679. (Pubitemid 40411095)
33. Kushi LH, Lew RA, Stare FJ, et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart study. N Engl J Med. 1985 ; 312: 811-818. (Pubitemid 15116925)
34. Dayton S., Hashimoto S., Pearce ML Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation. 1965 ; 32: 911-924.
35. Turpeinen O., Karvonen MJ, Pekkarinen M., Miettinen M., Elosuo R., Paavilainen E. Dietary prevention of coronary heart disease: Finnish Mental Hospital Study. Int J Epidemiol. 1979 ; 8: 99-118. (Pubitemid 10239890)
36. Singh RB, Dubnov G., Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002 ; 360: 1455-1461. (Pubitemid 35356323)
37. de Lorgeril M., Salen P., Martin JL, Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999 ; 99: 779-785. (Pubitemid 29083018)
38. Hu FB, Manson JE, Willett WC Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001 ; 20: 5-19. (Pubitemid 32244959)
39. Calder PC Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001 ; 36: 1007-1024. (Pubitemid 33065203)
40. Sprecher H. The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2002 ; 67: 79-83.
41. Rodriguez A., Sarda P., Nessmann C., Boulot P., Leger CL, Descomps B. Delta6- and delta5-desaturase activities in the human fetal liver: kinetic aspects. J Lipid Res. 1998 ; 39: 1825-1832. (Pubitemid 28411170)
42. Das UN A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids. 2007 ; 76: 251-268. (Pubitemid 46803265)
43. Calder PC Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002 ; 61: 345-358. (Pubitemid 34982924)
44. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003 ; 133: 925S - 932S. (Pubitemid 36262800)
45. Baylin A., Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol. 2006 ; 17: 22-27. (Pubitemid 43100299)
46. Gladman DD, Ibanez D., Urowitz MB Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291. (Pubitemid 34118775)
47. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640.
48. Gladman DD, Urowitz MB, Kagal A., Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol. 2000 ; 27: 377-379. (Pubitemid 30095467)
49. Abrahamowicz M., Fortin PR, du Berger R., Nayak V., Neville C., Liang MH The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol. 1998 ; 25: 277-284.
50. Folch J., Lees M., Sloane Stanley GH A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 ; 226: 497-509.
51. Ma DW, Ngo V., Huot PS, Kang JX N-3 polyunsaturated fatty acids endogenously synthesized in fat-1 mice are enriched in the mammary gland. Lipids. 2006 ; 41: 35-39.
52. Nikkari T., Luukkainen P., Pietinen P., Puska P. Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat. Ann Med. 1995 ; 27: 491-498.
53. Kim W., Chapkin RS, Barhoumi R., Ma DW A novel role for nutrition in the alteration of functional microdomains on the cell surface. Methods Mol Biol. 2009 ; 579: 261-70.
54. Davidson A., Diamond B. Autoimmune diseases. N Engl J Med. 2001 ; 345: 340-350.
55. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998 ; 41: 1714-1724. (Pubitemid 28465525)
56. Barnes EV, Narain S., Naranjo A., et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005 ; 14: 576-582. (Pubitemid 41296993)
57. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397. (Pubitemid 38419992)
58. Petri M., Roubenoff R., Dallal GE, Nadeau MR, Selhub J., Rosenberg IH Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet. 1996 ; 348: 1120-1124. (Pubitemid 26358611)
59. Nikpour M., Urowitz MB, Gladman DD Epidemiology of artherosclerosis in systemic lupus erythematosus. Curr Rheumatol Rep. 2009 ; 11: 248-254.
60. Qi KM, Hall M., Deckelbaum RJ Long-chain polyunsaturated fatty acid accretion in brain. Curr Opin Clin Nutr Metab Care. 2002 ; 5: 133-138.
61. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci. 2001 ; 16: 181-193. (Pubitemid 32664778)
62. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease. Prev Med. 2004 ; 39: 212-220. (Pubitemid 38797975)
63. von Schacky C., Harris WS Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007 ; 73: 310-315. (Pubitemid 44937689)
64. Kris-Etherton PM, Taylor DS, Yu-Poth S., et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000 ; 71 (1 suppl). 179S - 188S. (Pubitemid 30046114)
65. Emken EA, Adlof RO, Gulley RM Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. 1994 ; 1213: 277-288. (Pubitemid 24262911)
66. Pawlosky RJ, Hibbeln JR, Novotny JA, et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res. 2001 ; 42: 1257-1265. (Pubitemid 32744249)
67. Krauss RM, Eckel RH, Howard B., et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000 ; 102: 2284-2299.
68. Clark WF, Parbtani A., Huff MW, Reid B., Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int. 1989 ; 36: 653-660. (Pubitemid 19239557)
69. Walton AJ, Snaith ML, Locniskar M., Cumberland AG, Morrow WJ, Isenberg DA Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis. 1991 ; 50: 463-466.
70. Minami Y., Sasaki T., Arai Y., Kurisu Y., Hisamichi S. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients. J Rheumatol. 2003 ; 30: 747-754. (Pubitemid 36402768)
71. Caetano MC, Oritz TT, Terreri MT, et al. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus. J Pediatr. 2009 ; 85: 509-515.
72. Carmos MB, Toral N., Silva MV, Slater B. Consumo de doces, refrigerantes e bebidas com adição de açúcar entre adolescentes da rede pública de ensino de Piracicaba, São Paulo. Rev Bras Epidemiol. 2006 ; 9: 121-130. (Pubitemid 43799096)
73. Kazapi IM, Di Pietro PF, Avancini SR, Freitas SF, Tramonte VL Consumo de energia e macronutrientes por adolescentes de escolas públicas e privadas. Rev Nutr. 2001 ; 14: 27-33. (Pubitemid 34208496)
74. Roman MJ, Shanker B., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 2399-2406. (Pubitemid 37542988)